Postoperative respiratory failure

Contents

Overview

Postoperative pulmonary complications (PPCs) occur in 5–10% of surgical patients overall, rising to 20–40% after major abdominal and thoracic surgery. They are the leading cause of postoperative mortality and prolonged ICU stay. The spectrum ranges from atelectasis and pneumonia to respiratory failure requiring re-intubation. Identifying high-risk patients preoperatively and implementing lung-protective strategies throughout the perioperative period significantly reduces their incidence.

Risk Factors

Patient factors:

  • COPD (strongest predictor for PPCs)
  • Obstructive sleep apnoea (OSA)
  • Obesity (BMI >30)
  • Age >60
  • Active smoking, poor functional capacity
  • Pulmonary hypertension
  • Cardiac failure
  • Neuromuscular disease

Surgical factors:

  • Upper abdominal and thoracic surgery (highest risk — diaphragmatic dysfunction, pain limiting expansion)
  • Emergency surgery
  • Prolonged operative time (>3 hours)
  • Open surgery vs laparoscopic
  • Head and neck, aortic surgery

Anaesthetic factors:

  • Residual neuromuscular blockade (RNMB): the commonest modifiable intraoperative cause
  • Opioid-induced respiratory depression
  • High tidal volume or injurious intraoperative ventilation
  • Aspiration during induction or emergence

Risk scoring tools such as ARISCAT (Assess Respiratory Risk in Surgical Patients in Catalonia) provide structured preoperative stratification.

Causes

Atelectasis: The most common PPC. Reduced functional residual capacity (FRC), diaphragmatic splinting from pain, residual anaesthetic effects, and supine positioning all cause basal atelectasis. It may progress to pneumonia if secretions accumulate in collapsed segments.

Pneumonia: Hospital-acquired (HCAP) or aspiration pneumonia. High risk in prolonged intubation, post-oesophageal/upper GI surgery (disrupted swallow, aspiration risk).

Pulmonary oedema: Perioperative fluid overload causing cardiogenic oedema; unmasking of pre-existing LV dysfunction by the haemodynamic stresses of surgery.

Pulmonary embolism: VTE risk is elevated in the postoperative period. Submassive or massive PE can cause acute respiratory failure.

ARDS: Develops 12–48 hours after a pulmonary insult (aspiration, blood product transfusion — TRALI, sepsis, major surgery). Applies to postoperative patients without modification.

Residual neuromuscular blockade: Even partial RNMB impairs the hypoxic ventilatory drive and upper airway muscle tone, causing obstructive hypoventilation and aspiration on the ward or in recovery. Incidence with sugammadex-based reversal is substantially lower than with neostigmine, which cannot reliably reverse deep block.

Phrenic nerve injury: After cardiac surgery (phrenic nerve runs adjacent to the pericardium and is vulnerable to cold injury during cardioplegia) or thoracic surgery. Causes ipsilateral diaphragmatic paralysis and reduced VC, particularly significant in patients with pre-existing contralateral phrenic dysfunction.

Pneumothorax / haemothorax: After thoracic, upper GI, vascular, or central line insertion.

Diaphragmatic dysfunction: Post-cardiac and upper abdominal surgery. Paradoxical diaphragm motion and reduced diaphragm excursion contribute to postoperative atelectasis and respiratory failure.

Prevention: Perioperative Lung Protection

Intraoperative Ventilation

Lung-protective intraoperative ventilation reduces postoperative pulmonary complications. Evidence from PROVHILO, IMPROVE, and subsequent meta-analyses supports:

  • Low tidal volume: 6–8 mL/kg predicted body weight (IBW)
  • PEEP: 5–8 cmH2O (individualised based on intraoperative compliance and driving pressure)
  • Recruitment manoeuvres: after disconnection events or position changes
  • FiO2: minimise to lowest level maintaining SpO2 >95%; high FiO2 causes absorption atelectasis

Driving pressure (plateau pressure − PEEP) should be kept below 15 cmH2O where possible — driving pressure correlates with PPC risk across multiple studies.

Neuromuscular Blockade Reversal

Quantitative neuromuscular monitoring (train-of-four ratio) should confirm adequate reversal before extubation. Sugammadex allows complete reversal from deep block; neostigmine is unreliable below a train-of-four count of 2. RNMB at extubation significantly increases aspiration risk and upper airway obstruction.

Extubation Criteria

Standard criteria apply: reversal of neuromuscular block, adequate spontaneous respiratory effort, haemodynamic stability, adequate oxygenation on low FiO2, ability to protect the airway, and patient cooperation. Delayed extubation in selected high-risk patients (prolonged surgery, anticipated difficult airway, massive fluid shifts) may be appropriate.

Non-Invasive Ventilation

NIV (CPAP and bilevel ventilation) has an established role in postoperative respiratory management.

Prevention of re-intubation after planned extubation: High-flow nasal oxygen (HFNO) and prophylactic NIV reduce re-intubation rates in high-risk patients (hypoxaemic before extubation, COPD, obese, post-thoracic surgery).

Rescue after extubation failure: NIV can avoid re-intubation in carefully selected patients with early postoperative respiratory failure — particularly cardiogenic pulmonary oedema and COPD exacerbation. If NIV is not resolving hypoxaemia within 1–2 hours, re-intubation should not be delayed.

Post-thoracic surgery: NIV and HFNO reduce atelectasis and improve oxygenation after lung resection. Must be used with caution in the presence of bronchopleural fistula (risk of air leak worsening).

Obese patients and OSA: CPAP is recommended post-extubation. Pre-existing CPAP should be continued postoperatively. OSA patients are at high risk of airway obstruction and hypoxaemia in recovery.

Limitations of NIV: Contraindicated if the patient cannot protect the airway, is unable to cooperate, has significant GI surgery with risk of aspiration from positive pressure, or is haemodynamically unstable.

Management

Re-intubation: Do not delay when indicated. Prolonged attempts at NIV in a deteriorating patient increase the risk of uncontrolled emergency intubation. Anticipated difficulty — airway oedema after prolonged surgery, obesity, cervical immobility — should prompt senior involvement and preparation.

Atelectasis and secretion management: Chest physiotherapy, early mobilisation, adequate analgesia, and humidification are the mainstays. Flexible bronchoscopy to clear mucous plugging if lobar collapse does not respond to physiotherapy.

Analgesia optimisation: Pain causes splinting, reduces cough, and impairs deep breathing. For thoracic and upper abdominal surgery, thoracic epidural analgesia provides superior analgesia, reduces postoperative opioid requirement, and is associated with fewer pulmonary complications. Paravertebral, serratus anterior, and erector spinae plane blocks are alternatives when epidural is not feasible or fails.

Treat underlying cause: Antibiotics for pneumonia (guided by microbiology); diuresis for pulmonary oedema; anticoagulation for PE; drain for pneumothorax or haemothorax.

Tracheostomy: For patients expected to require prolonged ventilatory support, particularly those with pre-existing neuromuscular disease, bilateral phrenic injury, or severe ARDS. Early tracheostomy (7–10 days) facilitates weaning and reduces sedation requirements.

Viva Questions

What are the main risk factors for postoperative respiratory failure and how do you identify high-risk patients preoperatively?

Risk factors fall into patient, surgical, and anaesthetic categories. The strongest patient-related predictors are COPD, obstructive sleep apnoea, obesity, poor functional capacity, and active smoking. Surgical risk is highest with upper abdominal and thoracic procedures, emergency surgery, open versus laparoscopic approach, and prolonged operative time over three hours. Anaesthetic risk factors include anticipated residual neuromuscular blockade, perioperative aspiration risk, and high intraoperative tidal volumes. Structured risk scoring tools such as ARISCAT combine these factors into a quantitative risk score that guides preoperative planning and consent. High-risk patients should be identified in the preoperative assessment clinic to allow optimisation — smoking cessation, weight loss, pulmonary rehabilitation for COPD, CPAP titration for OSA — and to plan perioperative management, including the appropriate level of postoperative care and prophylactic NIV strategy. Intraoperative management should include lung-protective ventilation (low tidal volume 6–8 mL/kg IBW, PEEP 5–8 cmH2O, recruitment manoeuvres) and quantitative neuromuscular monitoring with sugammadex reversal to minimise residual paralysis.

How do you use NIV in the postoperative period and what are its limitations?

NIV has two distinct roles postoperatively: prophylactic use to prevent respiratory failure in high-risk patients and rescue therapy when early respiratory failure occurs after extubation. Prophylactic CPAP or bilevel NIV after upper abdominal or thoracic surgery reduces atelectasis, improves oxygenation, and lowers re-intubation rates in high-risk groups, including obese patients, those with COPD, and post-oesophagectomy patients. In rescue use, NIV is most effective for cardiogenic pulmonary oedema and hypercapnic respiratory failure in COPD — the clearest evidence base. It requires a patient who is cooperative, alert enough to protect their airway, able to tolerate the mask interface, and not haemodynamically unstable. A critical principle is that NIV should not be used as a reason to delay re-intubation in a patient who is deteriorating. If oxygenation or work of breathing is not improving within 60–90 minutes of NIV, or if the patient becomes less responsive, re-intubation is indicated. Using NIV to defer re-intubation leads to uncontrolled emergency intubations with worse outcomes. NIV is relatively contraindicated after some upper GI procedures where positive pressure may stress anastomoses or cause distension — this must be discussed with the surgical team on a case-by-case basis.

What is the evidence for intraoperative lung-protective ventilation and what parameters should be targeted?

The intraoperative ventilation strategy significantly influences the risk of postoperative pulmonary complications, regardless of whether the patient develops intraoperative respiratory failure. The PROVHILO trial found that high PEEP (12 cmH2O) with recruitment manoeuvres did not reduce PPCs compared with low PEEP (2 cmH2O) when tidal volumes were similar — suggesting that tidal volume, not PEEP alone, is the critical parameter. The IMPROVE trial demonstrated that individualised lung-protective ventilation (low TV 6–8 mL/kg IBW, moderate PEEP 6–8 cmH2O, recruitment manoeuvres) reduced major PPCs and hospital length of stay compared with conventional intraoperative ventilation in high-risk abdominal surgery patients. Meta-analyses confirm that low tidal volume, PEEP individualised to achieve best respiratory mechanics, and driving pressure below 15 cmH2O are the most consistently beneficial parameters. Driving pressure — the difference between plateau pressure and PEEP — integrates tidal volume and respiratory compliance into a single measure of lung strain, and associations between driving pressure and mortality have been demonstrated in both ARDS and non-ARDS operative patients. FiO2 should be the lowest level maintaining acceptable saturation to minimise absorption atelectasis. These principles apply throughout the operative period and should be maintained in ICU patients continuing on mechanical ventilation after surgery.